ARTICLE | Company News
DNA Therapeutics, Onxeo deal
March 7, 2016 8:00 AM UTC
Onxeo will acquire DNA Therapeutics for EUR1.7 million ($1.9 million) in stock up front. DNA Therapeutics, which develops signal-interfering DNA (siDNA) molecules for cancer indications, is also eligi...